Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 125,491.0 | $17.8M | 1.66% | NEW | — | $141.83 | +10.8% |
| 22 | PODD | INSULET CORP | Healthcare | 61,000.0 | $17.3M | 1.62% | NEW | — | $284.24 | -46.4% |
| 23 | DOCS | DOXIMITY INC | Healthcare | 372,750.0 | $16.5M | 1.54% | NEW | — | $44.28 | -55.8% |
| 24 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 193,500.0 | $16.5M | 1.54% | NEW | — | $85.25 | -3.4% |
| 25 | NUVL | NUVALENT INC | Healthcare | 163,350.0 | $16.4M | 1.54% | NEW | — | $100.59 | -0.7% |
| 26 | BIIB | BIOGEN INC | Healthcare | 92,350.0 | $16.3M | 1.52% | NEW | — | $175.99 | +8.3% |
| 27 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 34,255.0 | $15.5M | 1.45% | NEW | — | $453.36 | -3.7% |
| 28 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 146,263.0 | $15.5M | 1.45% | NEW | — | $106.14 | -0.0% |
| 29 | GILD | GILEAD SCIENCES INC | Healthcare | 126,150.0 | $15.5M | 1.45% | NEW | — | $122.74 | +5.6% |
| 30 | ALGN | ALIGN TECHNOLOGY INC | Healthcare | 99,000.0 | $15.5M | 1.45% | NEW | — | $156.15 | -0.6% |
| 31 | THC | TENET HEALTHCARE CORP | Healthcare | 76,504.0 | $15.2M | 1.42% | NEW | — | $198.72 | -3.2% |
| 32 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 215,000.0 | $12.8M | 1.19% | NEW | — | $59.43 | -16.4% |
| 33 | JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | 74,030.0 | $12.6M | 1.18% | NEW | — | $170.00 | +35.0% |
| 34 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 158,500.0 | $12.5M | 1.17% | NEW | — | $79.11 | -8.3% |
| 35 | AMGN | AMGEN INC | Healthcare | 36,000.0 | $11.8M | 1.10% | NEW | — | $327.31 | +1.1% |
| 36 | LIVN | LIVANOVA PLC | Healthcare | 190,000.0 | $11.7M | 1.09% | NEW | — | $61.53 | +17.4% |
| 37 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 19,550.0 | $11.4M | 1.06% | NEW | — | $582.34 | -10.3% |
| 38 | CI | THE CIGNA GROUP | Healthcare | 38,650.0 | $10.6M | 0.99% | NEW | — | $275.23 | +5.8% |
| 39 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 147,600.0 | $10.3M | 0.96% | NEW | — | $69.55 | -48.1% |
| 40 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 487,000.0 | $10.2M | 0.96% | NEW | — | $21.01 | -7.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%